Skip to main content
. Author manuscript; available in PMC: 2022 Feb 28.
Published in final edited form as: Eur J Pharm Biopharm. 2018 May 29;129:162–174. doi: 10.1016/j.ejpb.2018.05.033

Table 5.

Applied values to simulate the average gastric and duodenal concentrations of paromomycin as a function of time in fasted state conditions after oral administration.

Mean profile
t1/2 (min) antrum 2.71
t1/2 (min) body 22.1
t1/2 (min) bypass 6
t1/2 (min) duodenum 0.76
Fraction bypassed 0.49